RAPS: FDA Releases New Guidance for Clinical Evaluation of Irritable Bowel Syndrome Drugs
The US Food and Drug Administration (FDA) has released final guidance for industry to assist sponsors looking to develop drugs to treat patients suffering from irritable bowel syndrome (IBS). The 30 ...
FDA Releases New Guidance for Clinical Evaluation of Irritable Bowel Syndrome Drugs
Ironwood Pharmaceuticals develops drugs for the treatment of gastrointestinal diseases. The company recently launched its flagship product Linzess in the U.S to treat irritable bowel syndrome (IBS).
A massive, nearly 20-year study tracking over 650,000 Americans with irritable bowel syndrome is raising new questions about the long-term safety of common treatments. Researchers found that some ...
New research examines the long-term use of medication for irritable bowel syndrome and points to potential risks associated with some of the most widely used treatments.
A massive long-term study tracking more than 650,000 Americans with irritable bowel syndrome is raising new concerns about the safety of some commonly used treatments.
Commonly used medications for irritable bowel syndrome (IBS), like antidepressants, are linked to a modest absolute increase in mortality risk. | Drug Discovery And Development ...
Medindia: Irritable Bowel Syndrome Medication Use Linked To Higher Risk Of Death
Some Irritable bowel syndrome (IBS) medications show an association with increased long-term risk The overall risk for individual patients remains small, but it is important to consider Personalized ...
Phase 2 of the clinical study for the drug eluxadoline showed improvements for patients with irritable bowel syndrome with diarrhea over the placebo treatment, according to a Healio report. The trial ...
NDTV on MSN: Use of common irritable bowel syndrome medications like loperamide, diphenoxylate linked to higher death risks